Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/28/18
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 10/31/19
Due: 10/31/20
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 04/30/17
Due: 04/30/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE) | NCT03878303 | ACEA Therapeutics, Inc. | user2@example.com | None | 2018-11-28 | 2021-12-31 | 2022-12-31 | - | - | 2025-07-14 |
| Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer | NCT02448251 | ACEA Therapeutics, Inc. | user2@example.com | None | 2015-05-31 | 2019-10-31 | 2020-10-31 | - | - | 2025-07-14 |
| Study of AC0058TA in Healthy Male and Female Subjects | NCT02847325 | ACEA Therapeutics, Inc. | user2@example.com | None | 2016-05-31 | 2017-04-30 | 2018-04-30 | - | - | 2025-07-14 |